Morbidity of diverting stoma during colorectal surgery for deep infiltrating endometriosis - an observational study.


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 21 11 2021
revised: 28 01 2022
accepted: 24 02 2022
pubmed: 2 3 2022
medline: 6 4 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

To evaluate stoma-related complications after rectal resection and colorectal anastomosis with diverting stoma for deep infiltrating colorectal endometriosis. All the consecutive adult women who underwent colorectal resection with low anastomosis and diverting stoma for deep infiltrating endometriosis in one center between 2013 and 2020 were retrospectively included. Stoma-related complications were retrieved during the stoma period and after stoma reversal. 33 patients (mean age = 32 years (±6, range=24-45 years) were included. After the first surgery, overall and surgical morbidities were observed in 42% and 30% of patients, including stoma-related complications in 3 patients (9%): high output (n = 2) and prolapse (n = 1). One patient presented with rectovaginal fistula, requiring several unplanned surgeries. No anastomotic leakage was observed. All the patients underwent stoma reversal, after mean delay of 3 months (±3, range=1-20 months). Overall morbidity after stoma closure occurred in 9 patients (27%), including 1 major morbidity (digestive bleeding). Long-term results were obtained after a mean follow-up of 21 months (±9, range=14-34 months). Four patients presented with hernia at the stoma site (12%). The cumulative rate of stoma-related complications was 45%. There is no consensus about the impact of diverting stoma after rectal resection with colorectal anastomosis for deep infiltrating colorectal endometriosis. Stoma-related complications are frequently observed but there are major in only 12% of patients. High risk patients of rectovaginal fistula and/or anastomotic leakage need to be identified to better indicate the diverting stoma, waiting for randomized trials evaluating the real impact of diverting stoma.

Identifiants

pubmed: 35231644
pii: S2468-7847(22)00039-3
doi: 10.1016/j.jogoh.2022.102347
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

102347

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of Competing Interest None.

Auteurs

Diane Mège (D)

Department of General and Digestive Surgery, Timone University Hospital, Aix Marseille University APHM, 264 rue Saint-Pierre, Marseille, France. Electronic address: diane.mege@ap-hm.fr.

Clémentine Bernard (C)

Department of Gynecology, Aix Marseille University APHM, La Conception University Hospital, Marseille, France.

Audrey Pivano (A)

Department of Gynecology, Aix Marseille University APHM, La Conception University Hospital, Marseille, France.

Rémy Le Huu Nho (RLH)

Department of General and Digestive Surgery, Timone University Hospital, Aix Marseille University APHM, 264 rue Saint-Pierre, Marseille, France.

Mathilde Aubert (M)

Department of General and Digestive Surgery, Timone University Hospital, Aix Marseille University APHM, 264 rue Saint-Pierre, Marseille, France.

Julie Duclos (J)

Department of General and Digestive Surgery, Timone University Hospital, Aix Marseille University APHM, 264 rue Saint-Pierre, Marseille, France.

Aubert Agostini (A)

Department of Gynecology, Aix Marseille University APHM, La Conception University Hospital, Marseille, France.

Nicolas Pirro (N)

Department of General and Digestive Surgery, Timone University Hospital, Aix Marseille University APHM, 264 rue Saint-Pierre, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH